Doctor profile · Federal record

Dr. Philip Kovoor, MD

Medical Oncology Physician (CMS: Medical Oncology) · Internal Medicine Physician · Student in an Organized Health Care Education/Training Program · Plano, TX

  • NPI 1578714424
  • Accepts Medicare
  • MIPS 86.7 / 100 · 2023
  • 23 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
4708 Alliance Blvd, Suite 150
Plano, TX 750935340
(972) 596-7801
fax (972) 596-9307
Mailing address
Po Box 911230
Dallas, TX 753911230

Credentials & registration

NPPES · NUCC
NPI registered
October 2008 — 18 yrs on file
Profile last updated
September 16, 2010
Year of graduation
2003 — 23 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State license (1)
Texas #N2606
Medicaid (2)
TX #204403401 · TX #204403402

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1578714424. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
46,034
Distinct HCPCS
10
Medicare allowed
$896,622
HCPCS Description Services Patients Avg allowed
Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram 19,680 14 $0
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 12,230 24 $3
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 2,387 25 $0
J0897 Injection, denosumab, 1 mg 1,680 18 $23
J9395 Injection, fulvestrant, 25 mg 1,640 18 $10
36415 Insertion of needle into vein for collection of blood sample 1,121 503 $8
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 1,090 500 $8
80053 Blood test, comprehensive group of blood chemicals 999 450 $10
99214 Established patient office or other outpatient visit, 30-39 minutes 578 448 $122
J3489 Injection, zoledronic acid, 1 mg 521 80 $8

In context: peer comparison

Among 4 peers in Plano Medical Oncology Physician, average services per provider: 947. This provider delivers 49× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,074
Transactions
48
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 16 $246.84
Incyte Corporation 1 $99.95
Abbvie INC. 5 $95.87
Gilead Sciences, INC. 4 $81.54
Sirtex Medical INC 4 $79.00
Merck Sharp & Dohme LLC 4 $73.40
Kite Pharma, INC. 3 $57.19
E.R. Squibb & Sons, L.L.C. 3 $56.72
AstraZeneca Pharmaceuticals Lp 2 $32.72
Dendreon Pharmaceuticals LLC 1 $26.65
Daiichi Sankyo INC. 1 $26.28
Jazz Pharmaceuticals INC. 1 $25.30
Astellas Pharma US INC 1 $25.23
Pfizer INC. 1 $24.24
Takeda Pharmaceuticals U.S.A., INC. 1 $20.36

By nature of payment

Food and Beverage
$974
Education
$100

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
680
Patients
96
Total drug cost
$1,489,615
Drug Type Claims Patients Total cost
Anastrozole Generic 159 42 $4,950
Tamoxifen Citrate Generic 96 27 $2,764
Xtandi (Enzalutamide) Brand 69 0 $1,004,651
Xarelto (Rivaroxaban) Brand 44 14 $54,892
Prednisone Generic 42 0 $237
Hydroxyurea Generic 38 0 $880
Eliquis (Apixaban) Brand 36 0 $27,812
Acyclovir Generic 31 0 $472
Letrozole Generic 29 0 $726
Dexamethasone Generic 27 13 $171

Frequently asked questions

Auto-generated from federal data
What is Dr. Philip Kovoor's medical specialty?
Dr. Philip Kovoor practices Medical Oncology Physician in Plano, TX.
Where does Dr. Philip Kovoor practice?
Dr. Philip Kovoor practices at 4708 Alliance Blvd, Plano, TX 750935340. Office phone: 9725967801.
What is Dr. Philip Kovoor's NPI?
Dr. Philip Kovoor's National Provider Identifier (NPI) is 1578714424, issued by NPPES.
Does Dr. Philip Kovoor accept Medicare assignment?
Yes. Dr. Philip Kovoor accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Philip Kovoor commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS Q9967). Source: CMS Medicare Physician & Other Practitioners file.